MN
Mukund Narasimhan
About Mukund Narasimhan
Mukund Narasimhan has 14 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Human Robotics Private Limited and Aspirare Ventures Llp. Formerly with 2 companies, such as Xentrix Studios Private Limited and Supernova Arena Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Human Robotics Private Limited
U74110KA2014PTC072924
|
Director | 07 Jan 2014 | 2014 | Active |
Aspirare Ventures Llp
ACD-6206
|
Designated Partner | 26 Oct 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Xentrix Studios Private Limited
U74900KA2010PTC054156
|
Director | 15 Nov 2011 | 2010 | Active |
Supernova Arena Private Limited
U45400KA2013PTC071626
|
Director | 31 Oct 2013 | 2013 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukund Narasimhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukund Narasimhan
Mukund Narasimhan has 14 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Human Robotics Private Limited and Aspirare Ventures Llp. Formerly with 2 companies, such as Xentrix Studios Private Limited and Supernova Arena Private Limited. Engaged in General Business. Contributes to corporate operations.
Mukund Narasimhan is associated with 2 companies as Director and Designated Partner.
Mukund Narasimhan has expertise in General Business.
Mukund Narasimhan has 14 years in corporate governance.